Cadherin-11 Mediates Cancer Hijacking Fibroblasts
bioRxiv preprint doi: https://doi.org/10.1101/729491; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts Weirong Kang1Ϯ, Yibo Fan1Ϯ, Yinxiao Du1Ϯ, Elina A. Tonkova2, Yi-Hsin Hsu3, Kel Vin Tan4, Stephanie Alexander5, Bin Sheng Wong6, Haocheng Yang1, Jingyuan Luo1, Kuo Yao1, Jiayao Yang1, Xin Hu7, Tingting Liu8, Yu Gan8, Jian Zhang9, Jean J. Zhao10,11, Konstantinos Konstantopoulos6, Peter Friedl5, Pek Lan Khong4, Aiping Lu1, Mien-Chie Hung3,12, Michael B. Brenner2, Jeffrey E. Segall13, Zhizhan Gu1,2,6,10,13,# 1Centre for Cancer and Inflammation Research, Institute of Integrated Bioinformedicine and Translational Science, and School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China 2Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA 3Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA 4Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China 5Department of Cell Biology, RIMLS, Radboud University Medical Center, Nijmegen, The Netherlands; David H. Koch Center for Applied Research of Genitourinary Cancers, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston,
[Show full text]